Bronchiectasis: all 373 studies
Page 4 of 4. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- Inhaled Molgramostim (rhGM-CSF) in Healthy Adult SubjectsCompletedNCT02468908Phase 1
- Clinimetric Properties of Outcome Measures in Bronchiectasis in the UKCompletedNCT02468271
- The SENSOR Study: A Mixed-methods Study of SElf-management Checks to Predict exacerbatioNs of Pseudomonas Aeruginosa in Patients With Long-term reSpiratORy ConditionsCompletedNCT02458807
- Effects of Chest Physiotherapy (CPT) on Lung Clearance Index (LCI) in Non Cystic Fibrosis (CF) BronchiectasisCompletedNCT02411981Not applicable
- Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis BronchiectasisCompletedNCT02392663Not applicable
- Detection of Aspergillus Fumigatus and Sensitization in COPD Patients With Bronchiectasis vs Without BronchiectasisStatus unknownNCT02332122
- Long-term Airway Clearance Therapy in Non-cystic Fibrosis BronchiectasisCompletedNCT02324855Not applicable
- Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of BronchiectasisStatus unknownNCT02315547Not applicable
- Evaluation of Oscillatory Positive Expiratory Pressure (oPEP) in Bronchiectasis and COPDCompletedNCT02282202Not applicable
- Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation ProgramCompletedNCT02208830Not applicable
- Tayside Rehabilitation in Bronchiectasis Exacerbations (TRIBE) : a Randomized Controlled TrialTerminatedNCT02179983Not applicable
- Role of Innate Immunity in Non-Cystic Fibrosis BronchiectasisStatus unknownNCT02163642
- Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)CompletedNCT02104245Phase 3
- Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa InfectionStatus unknownNCT02102152Not applicable
- Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.TerminatedNCT02096315Phase 2
- Evaluation of the Safety of the Medical Device Simeox®TerminatedNCT02061852Not applicable
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy SubjectsTerminatedNCT02058407Phase 1
- Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With BronchiectasisCompletedNCT02048397Not applicable
- Bacterial Load Guided Therapy for Severe Bronchiectasis ExacerbationsCompletedNCT02047773Phase 4
- Epidemiology and Diagnosis of Haemoptysis: a Multicenter StudyCompletedNCT02045394
- Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT02035488Phase 1/2
- Impact of Chronic Air Pollution on Non-cystic Fibrosis BronchiectasisCompletedNCT01906047
- 3 Airway Clearance Techniques in Non Cystic Fibrosis BronchiectasisCompletedNCT01854788Not applicable
- Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) BronchiectasisCompletedNCT01818544Phase 2
- The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in AdultsStatus unknownNCT01801657
- The Sputum Colour Chart as a Predictor of Lung Inflammation and Proteolysis in Non-cystic Fibrosis BronchiectasisCompletedNCT01792440
- Mortality in Non-cystic Fibrosis BronchiectasisCompletedNCT01792427
- The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of BronchiectasisCompletedNCT01769898Phase 4
- Bacteriology and Inflammation in BronchiectasisStatus unknownNCT01761214Not applicable
- Efficacy of Vakum Technology in Patients With Chronic HypersecretionStatus unknownNCT01718067Not applicable
- The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF BronchiectasisStatus unknownNCT01688180
- The Effect of Theophylline in the Treatment of BronchiectasisCompletedNCT01684683Phase 4
- A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With BronchiectasisStatus unknownNCT01677403Phase 4
- Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis PatientsStatus unknownNCT01580748Phase 2
- ELTGOL and Bronchiectasis. Respiratory TherapyCompletedNCT01578681Not applicable
- Physical Activity in BronchiectasisCompletedNCT01569009
- Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)CompletedNCT01515007Phase 3
- Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory PassageCompletedNCT01480882Phase 2/3
- Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With BronchiectasisCompletedNCT01463371Not applicable
- Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and BronchiectasisStatus unknownNCT01410422
- The Incidence of Nontuberculous Mycobacterial Pulmonary Infection in Bilateral Bronchiectasis and BronchiolitisStatus unknownNCT01354912
- Bronchiectasis: Evaluation of an Educational InterventionWithdrawnNCT01315626
- Physiological Effects of Expiration With the Glottis Open in Lateral Posture (ELTGOL) and Flutter Valve in Patients With BronchiectasisCompletedNCT01300403Not applicable
- Atorvastatin in Bronchiectasis in Patients With Pseudomonas AeruginosaCompletedNCT01299194Phase 4
- A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis BronchiectasisCompletedNCT01299181Phase 4
- Prevention of Bronchiectasis in Infants With Cystic FibrosisCompletedNCT01270074Phase 3
- Exercise Capacity in Bronchiectasis ResectionStatus unknownNCT01268475
- Cross-sectional Characterization of Idiopathic BronchiectasisCompletedNCT01264055
- Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityTerminatedNCT01241942Not applicable
- Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency).TerminatedNCT01209546Phase 1
- Lymphocyte Immunophenotyping in Common Variable ImmunodeficiencyCompletedNCT01196702
- Expert Patient Self-management Programme Versus Usual Care in BronchiectasisCompletedNCT01117493Not applicable
- A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or BronchiectasisCompletedNCT01113034Phase 1
- Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in BronchiectasisStatus unknownNCT01112410Phase 2
- High Dose Inhaled Mannitol StudyCompletedNCT01076491Phase 1/2
- Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"CompletedNCT00889967Phase 2
- Exercise Training in Patients With Non-cystic Fibrosis (CF) BronchiectasisCompletedNCT00885521Phase 1
- Pulmonary Rehabilitation in Non Cystic Fibrosis BronchiectasisCompletedNCT00868075Phase 4
- Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?CompletedNCT00816309Phase 4
- Long Term Nebulised Gentamicin in Patients With BronchiectasisCompletedNCT00749866Phase 4
- A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler DeviceCompletedNCT00730977Phase 1/2
- Efficacy of Budesonide-Formoterol in BronchiectasisCompletedNCT00728715Not applicable
- The Prevalence of Gastro-oesophageal Reflux in Chronic Lung DiseaseCompletedNCT00697177
- Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis PatientsCompletedNCT00656721Not applicable
- Inspiratory Flow and Volumes in BronchiectaticsCompletedNCT00656565
- Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of ProphylaxisTerminatedNCT00524095Phase 2
- Airway Clearance in Bronchiectasis: is Non-Invasive Ventilation a Useful Adjunct in Moderate to Severe Disease?CompletedNCT00522314Not applicable
- Respiratory Muscle Strength in Bronchiectasis: Repeatability and ReliabilityCompletedNCT00487149
- The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT00484263Phase 3
- Bronchiectasis and Long Term Azithromycin TreatmentCompletedNCT00415350Phase 3
- Safety and Efficacy of Bronchitol in BronchiectasisCompletedNCT00277537Phase 3
- Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary RehabilitationStatus unknownNCT00129350Phase 1
- Diagnosis and Treatment of Patients With Cystic FibrosisTerminatedNCT00001223